Company intelligence / Profile preview

LyonLeaf Cannabis

Westmount/Montreal, Quebec, Canadalyonleaf.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

LyonLeaf Cannabis operates a GACP and EU GMP-certified facility in Montreal/Westmount, Quebec. The company produces ultra-premium cannabis for B2B markets worldwide, focusing on both medicinal and luxury segments. Their products are cultivated using scientific precision and artisanal care to ensure high quality. They have over 200 genetics/strains available and produce approximately 6,000 kg annually[2][3][4].

Therapeutic areas: OtherNeurology
Modalities: Plant-derived productSmall molecule (cannabinoids)
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on LyonLeaf Cannabis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LyonLeaf Cannabis.

Explore the full profile